ENO2 and neoplasm: In addition, the presence of circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and changes in the abundance of some proteins (CXCL10, ASPH, SPP2, ENO2, etc) all predicted the risk of postoperative recurrence 8-12.